How many employees does Arcosa have?
Arcus Biosciences, Inc. maintains a specialized biotechnology workforce of approximately 600 employees. Headquartered in Hayward, California, the clinical-stage biopharmaceutical company focuses on developing innovative cancer immunotherapies and combination regimens. Its professional team comprises oncological researchers, clinical trial managers, regulatory affairs experts, and laboratory scientists driving advanced pipeline studies.
Related FAQs
Aristocrat Leisure generates revenue primarily by manufacturing gaming machines, designing games, and providing gaming systems and consulting services.
Aedifica has maintained a solid financial performance, anchored by its robust portfolio of European healthcare real estate assets, strategic asset rotation initiatives, and disciplined capital management.
Executive compensation for Michael Arougheti, serving as the Chief Executive Officer of Ares Management Corporation, reflects elite leadership within the global alternative investment management sector.
Arcus Biosciences, Inc. commands a corporate market capitalization of approximately $3.36 billion USD (or roughly ₹367.67 billion).
Arcosa, Inc., which trades on the New York Stock Exchange under the ticker symbol ACA, is a fully transparent, publicly traded corporation.
Arcosa operates as a fully public corporate entity, listed and traded on the New York Stock Exchange under the ticker symbol ACA.